nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—CYP3A4—bone cancer	0.592	1	CbGaD
Doxepin—Clomipramine—GSTP1—bone cancer	0.00118	0.174	CrCbGaD
Doxepin—Olopatadine—CYP3A4—bone cancer	0.000866	0.127	CrCbGaD
Doxepin—Alimemazine—CYP3A4—bone cancer	0.00079	0.116	CrCbGaD
Doxepin—Cyclobenzaprine—CYP3A4—bone cancer	0.000728	0.107	CrCbGaD
Doxepin—Oxcarbazepine—CYP3A4—bone cancer	0.000666	0.098	CrCbGaD
Doxepin—Clomipramine—CYP3A4—bone cancer	0.000382	0.0563	CrCbGaD
Doxepin—Weight increased—Doxorubicin—bone cancer	0.00038	0.00146	CcSEcCtD
Doxepin—Urethral disorder—Methotrexate—bone cancer	0.000378	0.00146	CcSEcCtD
Doxepin—Sinusitis—Epirubicin—bone cancer	0.000377	0.00145	CcSEcCtD
Doxepin—Agranulocytosis—Epirubicin—bone cancer	0.000375	0.00144	CcSEcCtD
Doxepin—Pneumonia—Doxorubicin—bone cancer	0.000374	0.00144	CcSEcCtD
Doxepin—Nortriptyline—CYP3A4—bone cancer	0.000374	0.055	CrCbGaD
Doxepin—Infestation NOS—Doxorubicin—bone cancer	0.000372	0.00143	CcSEcCtD
Doxepin—Infestation—Doxorubicin—bone cancer	0.000372	0.00143	CcSEcCtD
Doxepin—Drowsiness—Doxorubicin—bone cancer	0.000372	0.00143	CcSEcCtD
Doxepin—Hypersensitivity—Cisplatin—bone cancer	0.000368	0.00142	CcSEcCtD
Doxepin—Bradycardia—Epirubicin—bone cancer	0.000367	0.00141	CcSEcCtD
Doxepin—Neuropathy peripheral—Doxorubicin—bone cancer	0.000365	0.0014	CcSEcCtD
Doxepin—Stomatitis—Doxorubicin—bone cancer	0.000363	0.0014	CcSEcCtD
Doxepin—Jaundice—Doxorubicin—bone cancer	0.000363	0.0014	CcSEcCtD
Doxepin—Urinary tract infection—Doxorubicin—bone cancer	0.000362	0.00139	CcSEcCtD
Doxepin—Hepatitis—Epirubicin—bone cancer	0.000361	0.00139	CcSEcCtD
Doxepin—Eye disorder—Methotrexate—bone cancer	0.00036	0.00139	CcSEcCtD
Doxepin—Tinnitus—Methotrexate—bone cancer	0.00036	0.00138	CcSEcCtD
Doxepin—Hypoaesthesia—Epirubicin—bone cancer	0.000359	0.00138	CcSEcCtD
Doxepin—Asthenia—Cisplatin—bone cancer	0.000358	0.00138	CcSEcCtD
Doxepin—Pharyngitis—Epirubicin—bone cancer	0.000358	0.00138	CcSEcCtD
Doxepin—Cardiac disorder—Methotrexate—bone cancer	0.000358	0.00138	CcSEcCtD
Doxepin—Sweating—Doxorubicin—bone cancer	0.000357	0.00137	CcSEcCtD
Doxepin—Urinary tract disorder—Epirubicin—bone cancer	0.000356	0.00137	CcSEcCtD
Doxepin—Oedema peripheral—Epirubicin—bone cancer	0.000356	0.00137	CcSEcCtD
Doxepin—Connective tissue disorder—Epirubicin—bone cancer	0.000355	0.00137	CcSEcCtD
Doxepin—Urethral disorder—Epirubicin—bone cancer	0.000354	0.00136	CcSEcCtD
Doxepin—Hepatobiliary disease—Doxorubicin—bone cancer	0.000352	0.00135	CcSEcCtD
Doxepin—Trimipramine—CYP3A4—bone cancer	0.000352	0.0518	CrCbGaD
Doxepin—Angiopathy—Methotrexate—bone cancer	0.00035	0.00135	CcSEcCtD
Doxepin—Sinusitis—Doxorubicin—bone cancer	0.000349	0.00134	CcSEcCtD
Doxepin—Immune system disorder—Methotrexate—bone cancer	0.000348	0.00134	CcSEcCtD
Doxepin—Mediastinal disorder—Methotrexate—bone cancer	0.000348	0.00134	CcSEcCtD
Doxepin—Agranulocytosis—Doxorubicin—bone cancer	0.000347	0.00134	CcSEcCtD
Doxepin—Chills—Methotrexate—bone cancer	0.000346	0.00133	CcSEcCtD
Doxepin—Diarrhoea—Cisplatin—bone cancer	0.000342	0.00132	CcSEcCtD
Doxepin—Alopecia—Methotrexate—bone cancer	0.000341	0.00131	CcSEcCtD
Doxepin—Bradycardia—Doxorubicin—bone cancer	0.00034	0.00131	CcSEcCtD
Doxepin—Mental disorder—Methotrexate—bone cancer	0.000338	0.0013	CcSEcCtD
Doxepin—Eye disorder—Epirubicin—bone cancer	0.000337	0.0013	CcSEcCtD
Doxepin—Tinnitus—Epirubicin—bone cancer	0.000337	0.0013	CcSEcCtD
Doxepin—Erythema—Methotrexate—bone cancer	0.000336	0.00129	CcSEcCtD
Doxepin—Malnutrition—Methotrexate—bone cancer	0.000336	0.00129	CcSEcCtD
Doxepin—Flushing—Epirubicin—bone cancer	0.000335	0.00129	CcSEcCtD
Doxepin—Cardiac disorder—Epirubicin—bone cancer	0.000335	0.00129	CcSEcCtD
Doxepin—Hepatitis—Doxorubicin—bone cancer	0.000334	0.00129	CcSEcCtD
Doxepin—Hypoaesthesia—Doxorubicin—bone cancer	0.000332	0.00128	CcSEcCtD
Doxepin—Pharyngitis—Doxorubicin—bone cancer	0.000332	0.00128	CcSEcCtD
Doxepin—Urinary tract disorder—Doxorubicin—bone cancer	0.00033	0.00127	CcSEcCtD
Doxepin—Oedema peripheral—Doxorubicin—bone cancer	0.000329	0.00127	CcSEcCtD
Doxepin—Dysgeusia—Methotrexate—bone cancer	0.000329	0.00127	CcSEcCtD
Doxepin—Connective tissue disorder—Doxorubicin—bone cancer	0.000328	0.00126	CcSEcCtD
Doxepin—Angiopathy—Epirubicin—bone cancer	0.000328	0.00126	CcSEcCtD
Doxepin—Urethral disorder—Doxorubicin—bone cancer	0.000327	0.00126	CcSEcCtD
Doxepin—Orphenadrine—CYP3A4—bone cancer	0.000327	0.0481	CrCbGaD
Doxepin—Immune system disorder—Epirubicin—bone cancer	0.000326	0.00126	CcSEcCtD
Doxepin—Mediastinal disorder—Epirubicin—bone cancer	0.000325	0.00125	CcSEcCtD
Doxepin—Back pain—Methotrexate—bone cancer	0.000325	0.00125	CcSEcCtD
Doxepin—Chills—Epirubicin—bone cancer	0.000324	0.00125	CcSEcCtD
Doxepin—Arrhythmia—Epirubicin—bone cancer	0.000322	0.00124	CcSEcCtD
Doxepin—Alopecia—Epirubicin—bone cancer	0.000319	0.00123	CcSEcCtD
Doxepin—Vomiting—Cisplatin—bone cancer	0.000318	0.00122	CcSEcCtD
Doxepin—Vision blurred—Methotrexate—bone cancer	0.000316	0.00122	CcSEcCtD
Doxepin—Mental disorder—Epirubicin—bone cancer	0.000316	0.00122	CcSEcCtD
Doxepin—Rash—Cisplatin—bone cancer	0.000315	0.00121	CcSEcCtD
Doxepin—Dermatitis—Cisplatin—bone cancer	0.000315	0.00121	CcSEcCtD
Doxepin—Erythema—Epirubicin—bone cancer	0.000314	0.00121	CcSEcCtD
Doxepin—Malnutrition—Epirubicin—bone cancer	0.000314	0.00121	CcSEcCtD
Doxepin—Eye disorder—Doxorubicin—bone cancer	0.000312	0.0012	CcSEcCtD
Doxepin—Ill-defined disorder—Methotrexate—bone cancer	0.000312	0.0012	CcSEcCtD
Doxepin—Tinnitus—Doxorubicin—bone cancer	0.000311	0.0012	CcSEcCtD
Doxepin—Anaemia—Methotrexate—bone cancer	0.00031	0.00119	CcSEcCtD
Doxepin—Cardiac disorder—Doxorubicin—bone cancer	0.00031	0.00119	CcSEcCtD
Doxepin—Flushing—Doxorubicin—bone cancer	0.00031	0.00119	CcSEcCtD
Doxepin—Flatulence—Epirubicin—bone cancer	0.00031	0.00119	CcSEcCtD
Doxepin—Tension—Epirubicin—bone cancer	0.000308	0.00119	CcSEcCtD
Doxepin—Dysgeusia—Epirubicin—bone cancer	0.000308	0.00118	CcSEcCtD
Doxepin—Desipramine—CYP3A4—bone cancer	0.000308	0.0453	CrCbGaD
Doxepin—Nervousness—Epirubicin—bone cancer	0.000305	0.00117	CcSEcCtD
Doxepin—Back pain—Epirubicin—bone cancer	0.000304	0.00117	CcSEcCtD
Doxepin—Angiopathy—Doxorubicin—bone cancer	0.000303	0.00117	CcSEcCtD
Doxepin—Malaise—Methotrexate—bone cancer	0.000303	0.00117	CcSEcCtD
Doxepin—Muscle spasms—Epirubicin—bone cancer	0.000302	0.00116	CcSEcCtD
Doxepin—Immune system disorder—Doxorubicin—bone cancer	0.000302	0.00116	CcSEcCtD
Doxepin—Vertigo—Methotrexate—bone cancer	0.000302	0.00116	CcSEcCtD
Doxepin—Mediastinal disorder—Doxorubicin—bone cancer	0.000301	0.00116	CcSEcCtD
Doxepin—Leukopenia—Methotrexate—bone cancer	0.000301	0.00116	CcSEcCtD
Doxepin—Chills—Doxorubicin—bone cancer	0.0003	0.00115	CcSEcCtD
Doxepin—Arrhythmia—Doxorubicin—bone cancer	0.000298	0.00115	CcSEcCtD
Doxepin—Promazine—CYP3A4—bone cancer	0.000298	0.0439	CrCbGaD
Doxepin—Nausea—Cisplatin—bone cancer	0.000297	0.00114	CcSEcCtD
Doxepin—Vision blurred—Epirubicin—bone cancer	0.000296	0.00114	CcSEcCtD
Doxepin—Alopecia—Doxorubicin—bone cancer	0.000295	0.00114	CcSEcCtD
Doxepin—Cough—Methotrexate—bone cancer	0.000293	0.00113	CcSEcCtD
Doxepin—Mental disorder—Doxorubicin—bone cancer	0.000293	0.00113	CcSEcCtD
Doxepin—Ill-defined disorder—Epirubicin—bone cancer	0.000292	0.00112	CcSEcCtD
Doxepin—Convulsion—Methotrexate—bone cancer	0.000291	0.00112	CcSEcCtD
Doxepin—Erythema—Doxorubicin—bone cancer	0.000291	0.00112	CcSEcCtD
Doxepin—Malnutrition—Doxorubicin—bone cancer	0.000291	0.00112	CcSEcCtD
Doxepin—Anaemia—Epirubicin—bone cancer	0.00029	0.00112	CcSEcCtD
Doxepin—Agitation—Epirubicin—bone cancer	0.000289	0.00111	CcSEcCtD
Doxepin—Flatulence—Doxorubicin—bone cancer	0.000287	0.0011	CcSEcCtD
Doxepin—Chest pain—Methotrexate—bone cancer	0.000286	0.0011	CcSEcCtD
Doxepin—Myalgia—Methotrexate—bone cancer	0.000286	0.0011	CcSEcCtD
Doxepin—Arthralgia—Methotrexate—bone cancer	0.000286	0.0011	CcSEcCtD
Doxepin—Tension—Doxorubicin—bone cancer	0.000285	0.0011	CcSEcCtD
Doxepin—Dysgeusia—Doxorubicin—bone cancer	0.000285	0.0011	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000284	0.00109	CcSEcCtD
Doxepin—Malaise—Epirubicin—bone cancer	0.000283	0.00109	CcSEcCtD
Doxepin—Discomfort—Methotrexate—bone cancer	0.000282	0.00109	CcSEcCtD
Doxepin—Nervousness—Doxorubicin—bone cancer	0.000282	0.00109	CcSEcCtD
Doxepin—Vertigo—Epirubicin—bone cancer	0.000282	0.00109	CcSEcCtD
Doxepin—Syncope—Epirubicin—bone cancer	0.000282	0.00108	CcSEcCtD
Doxepin—Leukopenia—Epirubicin—bone cancer	0.000281	0.00108	CcSEcCtD
Doxepin—Back pain—Doxorubicin—bone cancer	0.000281	0.00108	CcSEcCtD
Doxepin—Muscle spasms—Doxorubicin—bone cancer	0.00028	0.00108	CcSEcCtD
Doxepin—Palpitations—Epirubicin—bone cancer	0.000278	0.00107	CcSEcCtD
Doxepin—Confusional state—Methotrexate—bone cancer	0.000276	0.00106	CcSEcCtD
Doxepin—Loss of consciousness—Epirubicin—bone cancer	0.000276	0.00106	CcSEcCtD
Doxepin—Cough—Epirubicin—bone cancer	0.000274	0.00106	CcSEcCtD
Doxepin—Vision blurred—Doxorubicin—bone cancer	0.000274	0.00105	CcSEcCtD
Doxepin—Convulsion—Epirubicin—bone cancer	0.000272	0.00105	CcSEcCtD
Doxepin—Infection—Methotrexate—bone cancer	0.000272	0.00105	CcSEcCtD
Doxepin—Hypertension—Epirubicin—bone cancer	0.000271	0.00104	CcSEcCtD
Doxepin—Ill-defined disorder—Doxorubicin—bone cancer	0.00027	0.00104	CcSEcCtD
Doxepin—Nervous system disorder—Methotrexate—bone cancer	0.000269	0.00103	CcSEcCtD
Doxepin—Anaemia—Doxorubicin—bone cancer	0.000269	0.00103	CcSEcCtD
Doxepin—Thrombocytopenia—Methotrexate—bone cancer	0.000268	0.00103	CcSEcCtD
Doxepin—Arthralgia—Epirubicin—bone cancer	0.000268	0.00103	CcSEcCtD
Doxepin—Chest pain—Epirubicin—bone cancer	0.000268	0.00103	CcSEcCtD
Doxepin—Myalgia—Epirubicin—bone cancer	0.000268	0.00103	CcSEcCtD
Doxepin—Agitation—Doxorubicin—bone cancer	0.000267	0.00103	CcSEcCtD
Doxepin—Anxiety—Epirubicin—bone cancer	0.000267	0.00103	CcSEcCtD
Doxepin—Skin disorder—Methotrexate—bone cancer	0.000266	0.00102	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000266	0.00102	CcSEcCtD
Doxepin—Hyperhidrosis—Methotrexate—bone cancer	0.000265	0.00102	CcSEcCtD
Doxepin—Discomfort—Epirubicin—bone cancer	0.000264	0.00102	CcSEcCtD
Doxepin—Malaise—Doxorubicin—bone cancer	0.000262	0.00101	CcSEcCtD
Doxepin—Dry mouth—Epirubicin—bone cancer	0.000262	0.00101	CcSEcCtD
Doxepin—Vertigo—Doxorubicin—bone cancer	0.000261	0.00101	CcSEcCtD
Doxepin—Anorexia—Methotrexate—bone cancer	0.000261	0.00101	CcSEcCtD
Doxepin—Imipramine—CYP3A4—bone cancer	0.000261	0.0384	CrCbGaD
Doxepin—Syncope—Doxorubicin—bone cancer	0.000261	0.001	CcSEcCtD
Doxepin—Leukopenia—Doxorubicin—bone cancer	0.00026	0.001	CcSEcCtD
Doxepin—Amitriptyline—CYP3A4—bone cancer	0.000259	0.0382	CrCbGaD
Doxepin—Confusional state—Epirubicin—bone cancer	0.000259	0.000995	CcSEcCtD
Doxepin—Palpitations—Doxorubicin—bone cancer	0.000257	0.000989	CcSEcCtD
Doxepin—Oedema—Epirubicin—bone cancer	0.000256	0.000987	CcSEcCtD
Doxepin—Hypotension—Methotrexate—bone cancer	0.000256	0.000986	CcSEcCtD
Doxepin—Loss of consciousness—Doxorubicin—bone cancer	0.000256	0.000984	CcSEcCtD
Doxepin—Infection—Epirubicin—bone cancer	0.000255	0.000981	CcSEcCtD
Doxepin—Cough—Doxorubicin—bone cancer	0.000254	0.000977	CcSEcCtD
Doxepin—Shock—Epirubicin—bone cancer	0.000252	0.000971	CcSEcCtD
Doxepin—Convulsion—Doxorubicin—bone cancer	0.000252	0.00097	CcSEcCtD
Doxepin—Nervous system disorder—Epirubicin—bone cancer	0.000252	0.000968	CcSEcCtD
Doxepin—Thrombocytopenia—Epirubicin—bone cancer	0.000251	0.000967	CcSEcCtD
Doxepin—Hypertension—Doxorubicin—bone cancer	0.000251	0.000966	CcSEcCtD
Doxepin—Tachycardia—Epirubicin—bone cancer	0.00025	0.000963	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00025	0.000961	CcSEcCtD
Doxepin—Skin disorder—Epirubicin—bone cancer	0.000249	0.000959	CcSEcCtD
Doxepin—Hyperhidrosis—Epirubicin—bone cancer	0.000248	0.000954	CcSEcCtD
Doxepin—Insomnia—Methotrexate—bone cancer	0.000248	0.000954	CcSEcCtD
Doxepin—Myalgia—Doxorubicin—bone cancer	0.000248	0.000953	CcSEcCtD
Doxepin—Chest pain—Doxorubicin—bone cancer	0.000248	0.000953	CcSEcCtD
Doxepin—Arthralgia—Doxorubicin—bone cancer	0.000248	0.000953	CcSEcCtD
Doxepin—Anxiety—Doxorubicin—bone cancer	0.000247	0.00095	CcSEcCtD
Doxepin—Paraesthesia—Methotrexate—bone cancer	0.000246	0.000947	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000246	0.000946	CcSEcCtD
Doxepin—Discomfort—Doxorubicin—bone cancer	0.000245	0.000941	CcSEcCtD
Doxepin—Anorexia—Epirubicin—bone cancer	0.000244	0.000941	CcSEcCtD
Doxepin—Dyspnoea—Methotrexate—bone cancer	0.000244	0.00094	CcSEcCtD
Doxepin—Somnolence—Methotrexate—bone cancer	0.000244	0.000938	CcSEcCtD
Doxepin—Dry mouth—Doxorubicin—bone cancer	0.000242	0.000932	CcSEcCtD
Doxepin—Dyspepsia—Methotrexate—bone cancer	0.000241	0.000929	CcSEcCtD
Doxepin—Hypotension—Epirubicin—bone cancer	0.00024	0.000922	CcSEcCtD
Doxepin—Confusional state—Doxorubicin—bone cancer	0.000239	0.000921	CcSEcCtD
Doxepin—Decreased appetite—Methotrexate—bone cancer	0.000238	0.000917	CcSEcCtD
Doxepin—Oedema—Doxorubicin—bone cancer	0.000237	0.000913	CcSEcCtD
Doxepin—Gastrointestinal disorder—Methotrexate—bone cancer	0.000237	0.000911	CcSEcCtD
Doxepin—Fatigue—Methotrexate—bone cancer	0.000236	0.000909	CcSEcCtD
Doxepin—Infection—Doxorubicin—bone cancer	0.000236	0.000907	CcSEcCtD
Doxepin—Pain—Methotrexate—bone cancer	0.000234	0.000902	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000234	0.000899	CcSEcCtD
Doxepin—Shock—Doxorubicin—bone cancer	0.000233	0.000899	CcSEcCtD
Doxepin—Nervous system disorder—Doxorubicin—bone cancer	0.000233	0.000896	CcSEcCtD
Doxepin—Thrombocytopenia—Doxorubicin—bone cancer	0.000232	0.000894	CcSEcCtD
Doxepin—Insomnia—Epirubicin—bone cancer	0.000232	0.000893	CcSEcCtD
Doxepin—Tachycardia—Doxorubicin—bone cancer	0.000232	0.000891	CcSEcCtD
Doxepin—Skin disorder—Doxorubicin—bone cancer	0.00023	0.000887	CcSEcCtD
Doxepin—Paraesthesia—Epirubicin—bone cancer	0.00023	0.000886	CcSEcCtD
Doxepin—Hyperhidrosis—Doxorubicin—bone cancer	0.000229	0.000883	CcSEcCtD
Doxepin—Dyspnoea—Epirubicin—bone cancer	0.000229	0.00088	CcSEcCtD
Doxepin—Somnolence—Epirubicin—bone cancer	0.000228	0.000878	CcSEcCtD
Doxepin—Anorexia—Doxorubicin—bone cancer	0.000226	0.000871	CcSEcCtD
Doxepin—Feeling abnormal—Methotrexate—bone cancer	0.000226	0.000869	CcSEcCtD
Doxepin—Dyspepsia—Epirubicin—bone cancer	0.000226	0.000869	CcSEcCtD
Doxepin—Gastrointestinal pain—Methotrexate—bone cancer	0.000224	0.000863	CcSEcCtD
Doxepin—Decreased appetite—Epirubicin—bone cancer	0.000223	0.000858	CcSEcCtD
Doxepin—Hypotension—Doxorubicin—bone cancer	0.000222	0.000853	CcSEcCtD
Doxepin—Gastrointestinal disorder—Epirubicin—bone cancer	0.000221	0.000852	CcSEcCtD
Doxepin—Fatigue—Epirubicin—bone cancer	0.000221	0.000851	CcSEcCtD
Doxepin—Pain—Epirubicin—bone cancer	0.000219	0.000844	CcSEcCtD
Doxepin—Constipation—Epirubicin—bone cancer	0.000219	0.000844	CcSEcCtD
Doxepin—Urticaria—Methotrexate—bone cancer	0.000218	0.000838	CcSEcCtD
Doxepin—Abdominal pain—Methotrexate—bone cancer	0.000217	0.000834	CcSEcCtD
Doxepin—Body temperature increased—Methotrexate—bone cancer	0.000217	0.000834	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000216	0.000832	CcSEcCtD
Doxepin—Insomnia—Doxorubicin—bone cancer	0.000215	0.000826	CcSEcCtD
Doxepin—Paraesthesia—Doxorubicin—bone cancer	0.000213	0.00082	CcSEcCtD
Doxepin—Dyspnoea—Doxorubicin—bone cancer	0.000212	0.000814	CcSEcCtD
Doxepin—Feeling abnormal—Epirubicin—bone cancer	0.000211	0.000813	CcSEcCtD
Doxepin—Somnolence—Doxorubicin—bone cancer	0.000211	0.000812	CcSEcCtD
Doxepin—Gastrointestinal pain—Epirubicin—bone cancer	0.00021	0.000807	CcSEcCtD
Doxepin—Dyspepsia—Doxorubicin—bone cancer	0.000209	0.000804	CcSEcCtD
Doxepin—Decreased appetite—Doxorubicin—bone cancer	0.000206	0.000794	CcSEcCtD
Doxepin—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000205	0.000789	CcSEcCtD
Doxepin—Fatigue—Doxorubicin—bone cancer	0.000205	0.000787	CcSEcCtD
Doxepin—Urticaria—Epirubicin—bone cancer	0.000204	0.000784	CcSEcCtD
Doxepin—Pain—Doxorubicin—bone cancer	0.000203	0.000781	CcSEcCtD
Doxepin—Constipation—Doxorubicin—bone cancer	0.000203	0.000781	CcSEcCtD
Doxepin—Abdominal pain—Epirubicin—bone cancer	0.000203	0.00078	CcSEcCtD
Doxepin—Body temperature increased—Epirubicin—bone cancer	0.000203	0.00078	CcSEcCtD
Doxepin—Hypersensitivity—Methotrexate—bone cancer	0.000202	0.000777	CcSEcCtD
Doxepin—Asthenia—Methotrexate—bone cancer	0.000197	0.000757	CcSEcCtD
Doxepin—Feeling abnormal—Doxorubicin—bone cancer	0.000196	0.000753	CcSEcCtD
Doxepin—Gastrointestinal pain—Doxorubicin—bone cancer	0.000194	0.000747	CcSEcCtD
Doxepin—Pruritus—Methotrexate—bone cancer	0.000194	0.000746	CcSEcCtD
Doxepin—Hypersensitivity—Epirubicin—bone cancer	0.000189	0.000727	CcSEcCtD
Doxepin—Urticaria—Doxorubicin—bone cancer	0.000189	0.000726	CcSEcCtD
Doxepin—Body temperature increased—Doxorubicin—bone cancer	0.000188	0.000722	CcSEcCtD
Doxepin—Abdominal pain—Doxorubicin—bone cancer	0.000188	0.000722	CcSEcCtD
Doxepin—Diarrhoea—Methotrexate—bone cancer	0.000188	0.000722	CcSEcCtD
Doxepin—Asthenia—Epirubicin—bone cancer	0.000184	0.000708	CcSEcCtD
Doxepin—Pruritus—Epirubicin—bone cancer	0.000181	0.000698	CcSEcCtD
Doxepin—Dizziness—Methotrexate—bone cancer	0.000181	0.000698	CcSEcCtD
Doxepin—Diarrhoea—Epirubicin—bone cancer	0.000175	0.000675	CcSEcCtD
Doxepin—Hypersensitivity—Doxorubicin—bone cancer	0.000175	0.000673	CcSEcCtD
Doxepin—Vomiting—Methotrexate—bone cancer	0.000174	0.000671	CcSEcCtD
Doxepin—Rash—Methotrexate—bone cancer	0.000173	0.000665	CcSEcCtD
Doxepin—Dermatitis—Methotrexate—bone cancer	0.000173	0.000664	CcSEcCtD
Doxepin—Headache—Methotrexate—bone cancer	0.000172	0.000661	CcSEcCtD
Doxepin—Asthenia—Doxorubicin—bone cancer	0.00017	0.000655	CcSEcCtD
Doxepin—Dizziness—Epirubicin—bone cancer	0.00017	0.000653	CcSEcCtD
Doxepin—Pruritus—Doxorubicin—bone cancer	0.000168	0.000646	CcSEcCtD
Doxepin—Vomiting—Epirubicin—bone cancer	0.000163	0.000628	CcSEcCtD
Doxepin—Nausea—Methotrexate—bone cancer	0.000163	0.000627	CcSEcCtD
Doxepin—Diarrhoea—Doxorubicin—bone cancer	0.000162	0.000625	CcSEcCtD
Doxepin—Rash—Epirubicin—bone cancer	0.000162	0.000622	CcSEcCtD
Doxepin—Dermatitis—Epirubicin—bone cancer	0.000162	0.000622	CcSEcCtD
Doxepin—Headache—Epirubicin—bone cancer	0.000161	0.000618	CcSEcCtD
Doxepin—Dizziness—Doxorubicin—bone cancer	0.000157	0.000604	CcSEcCtD
Doxepin—Nausea—Epirubicin—bone cancer	0.000152	0.000586	CcSEcCtD
Doxepin—Vomiting—Doxorubicin—bone cancer	0.000151	0.000581	CcSEcCtD
Doxepin—Rash—Doxorubicin—bone cancer	0.00015	0.000576	CcSEcCtD
Doxepin—Dermatitis—Doxorubicin—bone cancer	0.000149	0.000575	CcSEcCtD
Doxepin—Headache—Doxorubicin—bone cancer	0.000149	0.000572	CcSEcCtD
Doxepin—Nausea—Doxorubicin—bone cancer	0.000141	0.000543	CcSEcCtD
Doxepin—CHRM1—Signaling Pathways—GNA11—bone cancer	2.83e-05	0.0002	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—GNA11—bone cancer	2.82e-05	0.0002	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—CYP3A4—bone cancer	2.8e-05	0.000199	CbGpPWpGaD
Doxepin—HRH2—Signaling by GPCR—EGFR—bone cancer	2.79e-05	0.000198	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—GNA11—bone cancer	2.79e-05	0.000198	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—GNA11—bone cancer	2.78e-05	0.000197	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IGF1R—bone cancer	2.75e-05	0.000195	CbGpPWpGaD
Doxepin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.75e-05	0.000195	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—JUN—bone cancer	2.71e-05	0.000192	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—ATF1—bone cancer	2.68e-05	0.00019	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TGFBR2—bone cancer	2.64e-05	0.000187	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—ATF1—bone cancer	2.64e-05	0.000187	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—ATF1—bone cancer	2.64e-05	0.000187	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—MMP9—bone cancer	2.63e-05	0.000187	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—ATF1—bone cancer	2.63e-05	0.000186	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—ATF1—bone cancer	2.62e-05	0.000186	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL3—bone cancer	2.62e-05	0.000186	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—GSTP1—bone cancer	2.61e-05	0.000185	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—ATF1—bone cancer	2.59e-05	0.000184	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—ATF1—bone cancer	2.59e-05	0.000183	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—GNA11—bone cancer	2.59e-05	0.000183	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL3—bone cancer	2.58e-05	0.000183	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL3—bone cancer	2.57e-05	0.000182	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL3—bone cancer	2.56e-05	0.000182	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL3—bone cancer	2.55e-05	0.000181	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TGFBR2—bone cancer	2.55e-05	0.000181	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TGFBR2—bone cancer	2.54e-05	0.00018	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL3—bone cancer	2.53e-05	0.000179	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—ENO2—bone cancer	2.53e-05	0.000179	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL3—bone cancer	2.52e-05	0.000179	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IGF1R—bone cancer	2.49e-05	0.000176	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TGFBR2—bone cancer	2.47e-05	0.000175	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—ENO2—bone cancer	2.47e-05	0.000175	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TGFBR2—bone cancer	2.43e-05	0.000172	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—MDM2—bone cancer	2.41e-05	0.000171	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—ATF1—bone cancer	2.4e-05	0.00017	CbGpPWpGaD
Doxepin—ADRA2B—Hemostasis—TP53—bone cancer	2.4e-05	0.00017	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IGF1R—bone cancer	2.4e-05	0.00017	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—GSTP1—bone cancer	2.4e-05	0.00017	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IGF1R—bone cancer	2.39e-05	0.000169	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—KIT—bone cancer	2.35e-05	0.000167	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL3—bone cancer	2.34e-05	0.000166	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—DHFR—bone cancer	2.34e-05	0.000166	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—ENO2—bone cancer	2.32e-05	0.000165	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IGF1R—bone cancer	2.32e-05	0.000165	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—ENO2—bone cancer	2.3e-05	0.000163	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—DHFR—bone cancer	2.29e-05	0.000162	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IGF1R—bone cancer	2.29e-05	0.000162	CbGpPWpGaD
Doxepin—ADRA2C—Hemostasis—TP53—bone cancer	2.24e-05	0.000159	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TGFBR2—bone cancer	2.24e-05	0.000159	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—KIT—bone cancer	2.22e-05	0.000157	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—BRAF—bone cancer	2.21e-05	0.000157	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TGFBR2—bone cancer	2.2e-05	0.000156	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TGFBR2—bone cancer	2.2e-05	0.000156	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TGFBR2—bone cancer	2.19e-05	0.000155	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—GNA11—bone cancer	2.19e-05	0.000155	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TGFBR2—bone cancer	2.18e-05	0.000155	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TGFBR2—bone cancer	2.16e-05	0.000153	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	2.16e-05	0.000153	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—DHFR—bone cancer	2.16e-05	0.000153	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—KIT—bone cancer	2.15e-05	0.000152	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—EGFR—bone cancer	2.14e-05	0.000152	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—GNA11—bone cancer	2.14e-05	0.000152	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—DHFR—bone cancer	2.14e-05	0.000152	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—EGFR—bone cancer	2.13e-05	0.000151	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—KIT—bone cancer	2.12e-05	0.000151	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IGF1R—bone cancer	2.11e-05	0.000149	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—JUN—bone cancer	2.1e-05	0.000149	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—BRAF—bone cancer	2.08e-05	0.000148	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IGF1R—bone cancer	2.07e-05	0.000147	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IGF1R—bone cancer	2.07e-05	0.000147	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IGF1R—bone cancer	2.06e-05	0.000146	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IGF1R—bone cancer	2.06e-05	0.000146	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—MMP9—bone cancer	2.04e-05	0.000145	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IGF1R—bone cancer	2.04e-05	0.000144	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IGF1R—bone cancer	2.03e-05	0.000144	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—EGFR—bone cancer	2.02e-05	0.000143	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—BRAF—bone cancer	2.02e-05	0.000143	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—GNA11—bone cancer	2.01e-05	0.000143	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	2e-05	0.000142	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—GNA11—bone cancer	2e-05	0.000142	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—KIT—bone cancer	2e-05	0.000142	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—BRAF—bone cancer	2e-05	0.000142	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—CYP3A4—bone cancer	1.99e-05	0.000141	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.98e-05	0.00014	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—ENO2—bone cancer	1.97e-05	0.00014	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—EGFR—bone cancer	1.96e-05	0.000139	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—CYP3A4—bone cancer	1.94e-05	0.000137	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—EGFR—bone cancer	1.93e-05	0.000137	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IGF1R—bone cancer	1.89e-05	0.000134	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—BRAF—bone cancer	1.88e-05	0.000133	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—MDM2—bone cancer	1.85e-05	0.000131	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CYP3A4—bone cancer	1.83e-05	0.00013	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—DHFR—bone cancer	1.83e-05	0.00013	CbGpPWpGaD
Doxepin—ADRA2A—Hemostasis—TP53—bone cancer	1.82e-05	0.000129	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—EGFR—bone cancer	1.82e-05	0.000129	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CYP3A4—bone cancer	1.81e-05	0.000128	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—KIT—bone cancer	1.8e-05	0.000128	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.8e-05	0.000128	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—TP53—bone cancer	1.79e-05	0.000127	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—MDM2—bone cancer	1.75e-05	0.000124	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—KIT—bone cancer	1.74e-05	0.000123	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—KIT—bone cancer	1.73e-05	0.000123	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—GNA11—bone cancer	1.71e-05	0.000121	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—GSTP1—bone cancer	1.7e-05	0.00012	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—BRAF—bone cancer	1.69e-05	0.00012	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—MDM2—bone cancer	1.69e-05	0.00012	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—KIT—bone cancer	1.68e-05	0.000119	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—MDM2—bone cancer	1.67e-05	0.000119	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—GSTP1—bone cancer	1.66e-05	0.000118	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—KIT—bone cancer	1.66e-05	0.000118	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—EGFR—bone cancer	1.65e-05	0.000117	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—EGFR—bone cancer	1.64e-05	0.000117	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—BRAF—bone cancer	1.64e-05	0.000116	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—BRAF—bone cancer	1.63e-05	0.000115	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—JUN—bone cancer	1.61e-05	0.000114	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—EGFR—bone cancer	1.59e-05	0.000112	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—BRAF—bone cancer	1.58e-05	0.000112	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—EGFR—bone cancer	1.58e-05	0.000112	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MDM2—bone cancer	1.57e-05	0.000112	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—MMP9—bone cancer	1.57e-05	0.000111	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—GSTP1—bone cancer	1.56e-05	0.000111	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—BRAF—bone cancer	1.56e-05	0.000111	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—GSTP1—bone cancer	1.55e-05	0.00011	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CYP3A4—bone cancer	1.55e-05	0.00011	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.54e-05	0.000109	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—EGFR—bone cancer	1.53e-05	0.000109	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—PTGS2—bone cancer	1.53e-05	0.000108	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—KIT—bone cancer	1.53e-05	0.000108	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ENO2—bone cancer	1.52e-05	0.000108	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—JUN—bone cancer	1.52e-05	0.000108	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—EGFR—bone cancer	1.51e-05	0.000107	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—KIT—bone cancer	1.5e-05	0.000107	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—KIT—bone cancer	1.5e-05	0.000106	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—KIT—bone cancer	1.5e-05	0.000106	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—KIT—bone cancer	1.49e-05	0.000106	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—MMP9—bone cancer	1.48e-05	0.000105	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—KIT—bone cancer	1.48e-05	0.000105	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—KIT—bone cancer	1.47e-05	0.000104	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—JUN—bone cancer	1.47e-05	0.000104	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—JUN—bone cancer	1.45e-05	0.000103	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—BRAF—bone cancer	1.44e-05	0.000102	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—MMP9—bone cancer	1.43e-05	0.000101	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MDM2—bone cancer	1.42e-05	0.000101	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—MMP9—bone cancer	1.41e-05	0.0001	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—BRAF—bone cancer	1.41e-05	0.0001	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—BRAF—bone cancer	1.41e-05	0.0001	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—DHFR—bone cancer	1.41e-05	0.0001	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—BRAF—bone cancer	1.41e-05	9.97e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—BRAF—bone cancer	1.4e-05	9.94e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—EGFR—bone cancer	1.39e-05	9.87e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—BRAF—bone cancer	1.39e-05	9.84e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—TP53—bone cancer	1.39e-05	9.83e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—BRAF—bone cancer	1.38e-05	9.82e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MDM2—bone cancer	1.37e-05	9.72e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—EGFR—bone cancer	1.37e-05	9.72e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—KIT—bone cancer	1.37e-05	9.7e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—JUN—bone cancer	1.37e-05	9.7e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—EGFR—bone cancer	1.37e-05	9.7e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MDM2—bone cancer	1.36e-05	9.67e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—EGFR—bone cancer	1.36e-05	9.66e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—EGFR—bone cancer	1.36e-05	9.63e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—PTGS2—bone cancer	1.35e-05	9.6e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—EGFR—bone cancer	1.34e-05	9.54e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—EGFR—bone cancer	1.34e-05	9.51e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MMP9—bone cancer	1.33e-05	9.43e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MDM2—bone cancer	1.33e-05	9.41e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—GSTP1—bone cancer	1.32e-05	9.39e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GNA11—bone cancer	1.32e-05	9.34e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MDM2—bone cancer	1.31e-05	9.26e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—BRAF—bone cancer	1.29e-05	9.12e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—EGFR—bone cancer	1.27e-05	8.98e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—EGFR—bone cancer	1.25e-05	8.84e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PTGS2—bone cancer	1.24e-05	8.81e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—JUN—bone cancer	1.23e-05	8.75e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MDM2—bone cancer	1.2e-05	8.54e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MMP9—bone cancer	1.2e-05	8.52e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—EGFR—bone cancer	1.19e-05	8.47e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—JUN—bone cancer	1.19e-05	8.45e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—JUN—bone cancer	1.19e-05	8.41e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MDM2—bone cancer	1.18e-05	8.4e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MDM2—bone cancer	1.18e-05	8.38e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MDM2—bone cancer	1.18e-05	8.35e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MDM2—bone cancer	1.17e-05	8.33e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MDM2—bone cancer	1.16e-05	8.25e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MDM2—bone cancer	1.16e-05	8.22e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MMP9—bone cancer	1.16e-05	8.22e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—EGFR—bone cancer	1.15e-05	8.19e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MMP9—bone cancer	1.15e-05	8.18e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—JUN—bone cancer	1.15e-05	8.18e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—EGFR—bone cancer	1.14e-05	8.11e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—JUN—bone cancer	1.13e-05	8.05e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MMP9—bone cancer	1.12e-05	7.96e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MMP9—bone cancer	1.1e-05	7.83e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MDM2—bone cancer	1.08e-05	7.64e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—EGFR—bone cancer	1.07e-05	7.62e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—TP53—bone cancer	1.06e-05	7.54e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—JUN—bone cancer	1.05e-05	7.42e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—JUN—bone cancer	1.03e-05	7.3e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—JUN—bone cancer	1.03e-05	7.28e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—JUN—bone cancer	1.02e-05	7.26e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GSTP1—bone cancer	1.02e-05	7.24e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—JUN—bone cancer	1.02e-05	7.24e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MMP9—bone cancer	1.02e-05	7.22e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—JUN—bone cancer	1.01e-05	7.17e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—JUN—bone cancer	1.01e-05	7.15e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TP53—bone cancer	1e-05	7.11e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MMP9—bone cancer	1e-05	7.1e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MMP9—bone cancer	9.99e-06	7.09e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MMP9—bone cancer	9.96e-06	7.06e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MMP9—bone cancer	9.93e-06	7.04e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MMP9—bone cancer	9.83e-06	6.97e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MMP9—bone cancer	9.8e-06	6.95e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—EGFR—bone cancer	9.7e-06	6.88e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TP53—bone cancer	9.7e-06	6.88e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TP53—bone cancer	9.6e-06	6.81e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—EGFR—bone cancer	9.37e-06	6.64e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—JUN—bone cancer	9.36e-06	6.64e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—EGFR—bone cancer	9.32e-06	6.61e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MMP9—bone cancer	9.11e-06	6.46e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—EGFR—bone cancer	9.06e-06	6.43e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TP53—bone cancer	9.02e-06	6.4e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—EGFR—bone cancer	8.92e-06	6.33e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTGS2—bone cancer	8.8e-06	6.24e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTGS2—bone cancer	8.59e-06	6.09e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—EGFR—bone cancer	8.22e-06	5.83e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TP53—bone cancer	8.15e-06	5.78e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTGS2—bone cancer	8.09e-06	5.74e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—EGFR—bone cancer	8.09e-06	5.74e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—EGFR—bone cancer	8.07e-06	5.73e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—EGFR—bone cancer	8.05e-06	5.71e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTGS2—bone cancer	8.02e-06	5.69e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—EGFR—bone cancer	8.02e-06	5.69e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—EGFR—bone cancer	7.94e-06	5.64e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—EGFR—bone cancer	7.92e-06	5.62e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TP53—bone cancer	7.86e-06	5.58e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TP53—bone cancer	7.82e-06	5.55e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TP53—bone cancer	7.61e-06	5.4e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TP53—bone cancer	7.49e-06	5.31e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—EGFR—bone cancer	7.36e-06	5.22e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TP53—bone cancer	6.9e-06	4.9e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTGS2—bone cancer	6.86e-06	4.86e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TP53—bone cancer	6.79e-06	4.82e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TP53—bone cancer	6.78e-06	4.81e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TP53—bone cancer	6.76e-06	4.79e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TP53—bone cancer	6.74e-06	4.78e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TP53—bone cancer	6.67e-06	4.73e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TP53—bone cancer	6.65e-06	4.72e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TP53—bone cancer	6.18e-06	4.38e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTGS2—bone cancer	5.29e-06	3.75e-05	CbGpPWpGaD
